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Abstract
Background: Survivin is the smallest member of the inhibitor of apoptosis (IAP) gene family.
Recently, the zebrafish survivin-1 gene has been cloned, showing remarkable sequence identity and
similarity over the BIR domain compared with human and mouse survivin  gene. Here we
investigated the role of survivin in angiogenesis during zebrafish development. Morpholinos (MOs)
targeting the 5' untranslated region (UTR) (SurUTR) and sequences flanking the initiation codon
(SurATG) of zebrafish survivin-1 gene were injected into embryos at 1–4 cell stage. Vasculature was
examined by microangiography and GFP expression in Tg(fli1:EGFP)y1 embryos. Results: In embryos
co-injected with SurUTR and SurATG-MOs, vasculogenesis was intact but angiogenesis was markedly
perturbed, especially in the inter-segmental vessels (ISV) and dorsal longitudinal anastomotic
vessels (DLAV) of the trunk, the inner optic circle and optic veins of developing eyes and the sub-
intestinal vessels. Apoptosis was increased, as shown by TUNEL staining and increase in caspase-3
activity. Efficacy of SurUTR and SurATG-MOs was demonstrated by translation inhibition of co-
injected 5'UTR survivin:GFP plasmids. The phenotypes could be recapitulated by splice-site MO
targeting the exon2-intron junction of survivin gene and rescued by survivin mRNA. Injection of
human vascular endothelial growth factor (VEGF) protein induced ectopic angiogenesis and
increased survivin expression, whereas treatment with a VEGF receptor inhibitor markedly
reduced angiogenesis and suppressed survivin expression. Conclusion: Survivin is involved in
angiogenesis during zebrafish development and may be under VEGF regulation.
Background
Survivin is the smallest member of the inhibitor of apop-
tosis (IAP) gene family containing a single Baculovirus
IAP Repeat (BIR) domain and an extended -COOH termi-
nal α-helical coiled coil [1]. Survivin is not expressed in
most normal adult tissues but is highly expressed in solid
and hematological malignancies, where it has been linked
to increased angiogenesis and tumorigenesis [2,3]. During
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human and murine embryonic development, survivin is
ubiquitously expressed [4]. However, homozygous
knock-out of survivin in mouse ES cells results in disrupted
microtubule formation and polyploidy as well as early
embryonic fatality, precluding characterization of its func-
tions during murine development [5]. As a result, the role
of survivin during embryonic development remains
unclear.
Recently, the zebrafish survivin-1 gene (abbreviated sur-
vivin) has been cloned, showing remarkable sequence
identity and similarity over the BIR domain compared
with human and mouse survivin gene [6]. Microarray anal-
ysis showed that survivin is significantly up-regulated in a
zebrafish chordin morphant in which the intermediate cell
mass (ICM, where vascular and primitive hematopoietic
tissues arise) was expanded [7]. Here, we investigated if
survivin plays a role in vascular formation during
zebrafish embryonic development.
Results
Expression of survivin in zebrafish embryos
Whole-mount  in-situ  hybridization was performed to
examine survivin mRNA expression in zebrafish embryos
at 26 hpf. Survivin was detected diffusely throughout the
developing brain and neural tube. It was also expressed at
the vicinity of the axial vasculature from which the inter-
segmental vessels arise (Figure 1a–b). This was further
confirmed in histological sectioning in which the areas
corresponding to the developing axial vasculature and
neural tube showed increased expression relative to the
adjacent tissues (Figure 1b, insert). Furthermore, double
in-situ hybridization showed that survivin was expressed in
the developing axial vasculature dorsal to the intermedi-
ate cell mass (ICM), where gene encoding for embryonic
hemoglobin α was expressed. The pattern was remarkably
similar to that of flk1, a VEGF receptor tyrosine kinase
(Figure 1c–d).
Survivin morphants
The role of survivin during embryonic development was
investigated by knocking-down its function using MOs.
The phenotypic penetrance of survivin MOs was dose- and
time-dependent. At 22 hpf, when injected with either 3 ng
SurUTR or 3 ng SurATG-MOs (referred as SurUTR
mo and SurAT-
G
mo embryos), most embryos had a relatively normal mor-
phology (Figure 2a,c). However, at 48 hpf, 74.8 ± 7.3%
and 72.0 ± 4.0% of embryos manifested "characteristic
phenotypes" with reduced eye and head sizes and a mildly
curved tail (Figure 2b,d). There was no overt tissue necro-
sis in these embryos. At 6 ng of either MOs, increasing
numbers of embryos became severely deformed and died
shortly after 48 hpf (Figure 2d, insert). Co-injecting SurATG
+ SurUTR-MOs (3 ng each) resulted in specific phenotypes
in 79.4 ± 7.2% embryos without increase in toxicity or
mortality as compared with 3 ng of either MO alone (Fig-
ure 2e). The combination regimen remained significantly
less toxic than that of SurUTR-MO at 6 ng. In all subsequent
experiments, SurATG and SurUTR-MOs were co-injected at 3
ng each (referred as SurUTR+ATG
mo  embryos). Only
embryos with characteristic phenotypes were investigated
while those which were severely deformed were excluded
from analysis.
Effects of survivin knock-down on angiogenesis
We have previously shown that survivin is significantly up-
regulated in a zebrafish chordin morphant in which the
ICM was expanded [7]. Therefore, we first examined the
effects of survivin knock-down on vascular formation in
Tg(fli1:EGFP)y1 embryos. In uninjected embryos, the axial
circulation (AC), inter-segmental vessels (ISV), dorsal lon-
gitudinal anastomotic vessels (DLAV), vertebral and sub-
intestinal vessels (SIV) were readily observable (Figure
3a,c). In SurUTR+ATG
mo embryos, the dorsal aorta and pos-
terior cardinal vein were patent, indicative of intact vascu-
logenesis (see additional file 1: Wild-type embryos and
file 2: Survivin morphants). However, the development of
vertebral and ISV was perturbed with defective or total
absence of sprouting as well as failure to form the DLAV
and SIV (Figure 3b,d). These defects were seen in all 54
SurUTR+ATG
mo embryos observed (n = 3 separate experi-
ments) with the characteristic phenotypes. The results
were confirmed using microangiography in which defec-
tive ISV sprouting and failure to form the DLAV, as well as
defective inner optic circle (IOC) and optic veins (OV) of
the developing eyes were seen in the SurUTR+ATG
mo
embryos (Figure 3e–h). Similar patterns of angiogenesis
defects were observed when either SurUTR or SurATG mor-
pholinos were injected (data not shown).
Effects of survivin MOs on apoptosis as shown by TUNEL 
and caspase-3 activity
As a member of the IAP family, survivin has been shown
to inhibit apoptosis by regulating caspase activity [1,2].
Therefore; we investigated if there was increased apoptosis
in the SurUTR+ATG
mo embryos as measured by TUNEL assay.
At both 24 and 48 hpf, increased TUNEL staining was
detected in the developing neural tube and the brain (not
shown), with significant, albeit weaker, staining at the
vicinity of the axial vasculature (Figure 3i,j). The increased
apoptosis was further confirmed by specific caspase-3
activity which was significantly increased in 48 hpf
SurUTR+ATG
mo embryos (299.1 ± 8.3 arbitrary units) com-
pared with control embryos injected with a random
sequence MO at 6 ng (103.0 ± 2.3 arbitrary units, n = 3
experiments using 240 embryos, p < 0.05).
Specificity of survivin knock-down
To further demonstrate the efficacy of SurUTR and SurATG
MO binding to survivin mRNA, embryos were co-injectedBMC Developmental Biology 2007, 7:50 http://www.biomedcentral.com/1471-213X/7/50
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with a 5'UTR survivin:GFP plasmid (50 pg) and
SurUTR+ATG-MOs (3 ng each). Injecting the plasmid alone
lead to GFP expression in 79.7 ± 9.4% embryos (Figure
4a,c). Co-injection of the plasmid with SurUTR+ATG-MOs
completely abolished protein translation and hence GFP
expression in all embryos tested (Figure 4b,d). A splice site
MO (SurSS-MO (12 ng)) not only induced similar mor-
phological changes as in SurUTR+ATG
mo embryos (smaller
head and eye size and mildly curved tail) but also induced
defective angiogenesis as shown in Tg(fli1:EGFP)y1
embryos (61.7%, n = 3 experiments using 159 embryos)
(Figure 4e–f). Angiogenesis defects were seen in ISV as
well as OV/IOC of the developing eyes (not shown). A rel-
atively high dose of MO (12 ng) was used as lower doses
Effects of survivin knock-down on embryonic development Figure 2
Effects of survivin knock-down on embryonic development. 
(a, b): Wild-type (WT) embryos injected with random 
sequence morpholino at 22 hpf (a) and 48 hpf (b). (c, d): 
Embryos injected with a combination of SurATG (3 ng) and 
SurUTR morpholinos (3 ng) (SurATG+UTR) at 1–4 cell stage. 
Noted that while there was no significant morphological 
changes at 22 hpf, most of the embryos injected with 
SurATG+UTR morpholinos at 48 hpf showed a "characteristic 
phenotype" with reduced head and eye size (circled) and a 
mildly curved tail (arrowheads). Similar phenotypes were 
also seen in embryos injected with either SurATG or SurUTR 
morpholinos at various doses but not in WT embryos 
injected with random sequence. Insert (d) showed a severe 
phenotype at 48 hpf characterized by severely deformed 
embryos which did not survive beyond 48 hpf. These 
embryos were not included in the analysis. Each picture is 
representative of at least three experiments. (e): The dose-
dependence of either SurATG, SurUTR or SurATG+UTR mor-
pholinos. Optimal response was observed when embryos 
were co-injected with 3 ng of each MO (SurUTR+ATG). Results 
were expressed as mean ± S.E.M. In each experiment, MOs 
at different doses were injected into the same batch of 
embryos and were scored at the same time. More than 40 
embryos have been injected at each dosage.
Whole-mount in-situ hybridization showing the expression  of survivin in zebrafish embryos Figure 1
Whole-mount in-situ hybridization showing the expression 
of survivin in zebrafish embryos. (a, b): Survivin is expressed 
diffusely in the developing central nervous system (white 
arrows) and the axial vasculature (arrowheads) at 26 hpf. 
Similar expression patterns were seen at 56 hpf (not shown). 
(b, insert): Coronal section of stained embryos at 26 hpf 
showing preferential expression of survivin at the vicinity of 
the dorsal aorta and the developing neural tube (circled). (c, 
d): Double in-situ hybridization showing remarkably similar 
expression pattern of survivin (c) and flk1 (d) (blue, dark 
arrowheads) in relation to that of embryonic hemoglobin-α 
(brown, white arrowheads). Pictures are representative of at 
least three separate experiments. NT: Neural Tube; M: Myo-
tome; N: Notochord; Y: Yolk sac extension.BMC Developmental Biology 2007, 7:50 http://www.biomedcentral.com/1471-213X/7/50
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produced less phenotypic penetrance and at 12 ng, there
was no excessive mortality. In the SurSS
MO embryos, RT-
PCR confirmed defective splicing of part of the intron, as
shown by a larger PCR transcript which was verified by bi-
directional DNA sequencing (Figure 4g,h). Whether
defective splicing could be induced by lower doses of this
MO has not been examined. Finally, defective sprouting
or failure to form the DLAV occurred in all SurUTR+ATG
mo
embryos and co-injecting survivin  mRNA (30 pg) with
SurUTR+ATG-MOs rescued the vascular defect in 47 out of
58 embryos in three separate experiments (81%) (Figure
4i–l).
Effects of VEGF on survivin expression
VEGF plays an important role in angiogenesis during
zebrafish embryonic development [8]. In-vitro  studies
have shown that survivin mediates the proliferative and
anti-apoptotic effects of VEGF in endothelial cells [9].
Therefore; we investigated if survivin  expression during
embryogenesis is regulated by VEGF. Exogenous human
VEGF protein (2 ng) was injected into zebrafish embryos
at one-cell stage [10]. Angiogenesis was examined in the
sub-intestinal vessels at 96 hpf, where the vasculature was
well-developed and any ectopic structures could be read-
ily detectable. In 78 out of 110 embryos (70%) (from
three separate experiments), VEGF induces ectopic angio-
genesis which was associated with a significant up-regula-
tion of survivin mRNA expression (Figure 5a–b,f). We also
incubated embryos with a VEGF receptor inhibitor
(VEGFTKR) at one-cell stage. VEGFTKR (25 μmol/L)
induced defective angiogenesis in all treated embryos at
48 hpf (Figure 5c–d) and could not be rescued by survivin
mRNA injection (30 pg) (Figure 5e). Survivin  mRNA
expression was significantly down-regulated in these
embryos (Figure 5f).
Discussion
In this study, we demonstrated that knock-down of sur-
vivin with MOs gives rise to embryos with reduced eye and
head sizes and a mildly curved tail. Similar phenotypic
changes have been described in a survivin mutant gener-
ated in a retrovirus insertional mutagenesis screen [11].
The  survivin  morphants had defective angiogenesis but
vasculogenesis, i.e. formation of axial vasculature, was not
affected at the doses of MOs tested. Development delay in
these morphants was not observed, as shown by the nor-
mal onset and pattern of pigmentation and heart beat
(data not shown). Our results corroborate with in-vitro
studies showing that survivin is important for the mainte-
nance of proliferation and survival on endothelial cells
[9,12]. In addition, our data provided new information
on the role of survivin during embryonic development.
In-vitro and tumorigenesis studies have shown that sur-
vivin mediates the angiogenic effects of VEGF [9,12,13].
In zebrafish embryos, VEGF signaling is important for
angiogenesis. In particular, mutants defective in a
Effects of survivin knock-down on angiogenesis and circulation Figure 3
Effects of survivin knock-down on angiogenesis and circula-
tion. (a, b): Confocal microscopy of Tg(fli1:EGFP)y1 embryos 
either uninjected (a) or injected with SurUTR+ATG mor-
pholinos (b). Noted the aberrant sprouting of the inter-seg-
mental vessels (ISV) (arrowheads), the absence of vertebral 
arteries (arrows) and the failure to form the dorsal anasto-
motic vessels (DLAV) in the SurUTR+ATG
MO embryos. AC: 
Axial circulation. Noted that the dorsal aorta and posterior 
cardinal vein in the axial circulation could not be distin-
guished based on the resolution provided. (c, d): Fluorescent 
images in Tg(fli1:EGFP)y1 embryos showing failure to develop 
the sub-intestinal vessels (SIV) in SurUTR+ATG
MO embryos. (e-
h): Microangiographic pictures in uninjected (e, g) and 
SurUTR+ATG
MO embryos (f, h) showing defective vasculatures 
in ISV, DLAV, optical veins (OV) and inner optic circle (IOC). 
N: Notochord; AC: Axial circulation. (i, j): Whole-mount 
TUNEL assay in embryos injected with random sequence 
MO (i) and SurUTR+ATG-MO (j) showing positive staining in 
the area of developing neural tube and brain (white arrows) 
as well as at the vicinity of the axial circulation (white arrow-
heads) in the SurUTR+ATG
MO embryos. N: Notochord; Y: Yolk 
sac extension. Embryos were examined at 48 hpf except (c) 
& (d) which were examined at 96 hpf. More than 20 embryos 
have been examined in each experiment.BMC Developmental Biology 2007, 7:50 http://www.biomedcentral.com/1471-213X/7/50
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zebrafish orthologue of flk1 (a VEGF-receptor tyrosine
kinase), the schwentine [14], and in phospholipase Cγ (a
tyrosine kinase mediating effects of VEGFR), the y10 [15],
exhibit specific defects in angiogenesis. MO targeting of
VEGF results in defective circulation in the head, axial and
inter-segmental vasculature in a dose-dependent fashion
[8]. In this study, VEGF induces ectopic angiogenesis and
up-regulates  survivin  mRNA expression, suggesting that
survivin may mediate the angiogenic effect of VEGF. The
link between VEGF and survivin during zebrafish angio-
genesis has not been examined but may involve PKB/Akt
signaling as reported in human endothelial cell lines [16].
Intriguingly, co-injecting embryos with survivin mRNA
could only rescue the vascular defects seen in
SurUTR+ATG
MO embryos but not in embryos treated with a
VEGF receptor inhibitor. Therefore, additional down-
stream mediators may be involved in the angiogenic
effects of VEGF [17]. Reversely, whether VEGF can rescue
the angiogenesis defects in SurUTR+ATG
MO embryos has not
been examined. Perturbation of VEGF signaling may also
result in changes in blood vessel synthesis and the
observed changes in survivin mRNA may reflect changes
in endothelial cell number rather than a direct mechanis-
tic link to VEGF signaling. This issue would have to be
evaluated in future study.
Both human and murine studies have demonstrated that
survivin is involved in haematopoietic stem and progeni-
tor cell proliferation [18,19]. However, in the present
study, early specification of hematopoietic progenitors in
the SurUTR+ATG
MO embryos was not affected, as shown by
the normal expression of genes encoding for hematopoi-
etic transcription factors and embryonic hemoglobins, as
well as the normal distribution of gata1+ population in
Tg(gata1:GFP)  embryos at 18 hpf, before the onset of
functional circulation (data not shown).
That the targeting of the survivin MOs was specific was
shown using several control studies. First, the phenotypic
changes seen in SurUTR+ATG
MO embryos were similar to
those observed in survivin mutants generated by retrovirus
insertional mutagenesis screening [11]. Indeed, it would
be valuable to examine this mutant for similar defects in
angiogenesis. Second, co-injecting SurUTR+ATG-MO with a
5'UTR-survivin:GFP plasmid inhibited translation and
hence green fluorescence induced by the latter in all
embryos, proving efficacious binding of SurUTR+ATG-MO to
the 5'UTR-survivin mRNA. Third, the angiogenesis defects
of ISV induced by SurUTR+ATG-MO could be rescued by sur-
vivin mRNA. Whether the defects in SIV and OV/IOC were
similarly reversed and whether injection of survivin
mRNA alone would induce angiogenesis defects would
have to be further examined. Finally a splice-site mor-
pholino recapitulated the phenotypes seen with
SurUTR+ATG-MO. Therefore, the angiogenesis defects in
SurUTR+ATG
MO embryos represent a specific phenotype due
to knock-down of survivin function in zebrafish embryos.
In human, murine [4] as well as Xenopus embryos [20],
survivin  is ubiquitously expressed. These observations,
together with the fact that the developing head and eye of
the SurUTR+ATG
MO  embryos were reduced in size have
Effect of survivin knock-down was gene-specific Figure 4
Effect of survivin knock-down was gene-specific. (a-d): Injec-
tion of 5'UTR-survivin:GFP plasmids gave rise to green fluo-
rescence in a mosaic pattern in 79.7 ± 9.4% (a, c) which was 
totally abolished by co-injection with SurUTR+ATG-MO (b, d). 
(e): Uninjected Tg(fli1:EGFP)y1 embryos at 48 hpf. (f): Defec-
tive sprouting of inter-segmental vessels, similar to those 
seen in SurUTR+ATG
MO embryos, could be recapitulated by 
injecting embryos with survivin morpholino targeting the 
splice-site junction (g). (h): Molecular targeting was con-
firmed using RT-PCR showing survivin gene in injected 
embryos contained a larger transcript compared with unin-
jected ones. (i-k): Defective angiogenesis in SurUTR+ATG
MO 
embryos could be rescued by co-injecting with survivin 
mRNA. (i): Uninjected embryos. (j): SurUTR+ATG
MO embryos. 
(k): SurUTR+ATG
MO embryos co-injected with survivin mRNA. 
(i): Histogram showing average number of embryos with nor-
mal inter-segmental vessels (ISV) in three separate experi-
ments. All embryos were oriented anterior (left) to 
posterior (right).BMC Developmental Biology 2007, 7:50 http://www.biomedcentral.com/1471-213X/7/50
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raised a concern whether the angiogenesis defects in these
embryos might be caused by a general developmental
defect and cell death, rather than a specific requirement
for survivin function. However, in zebrafish embryos, sur-
vivin is more robustly expressed in the axial vasculature as
well as the developing brain and neural tube. This obser-
vation has been confirmed by histological sectioning as
well as double in-situ hybridization in which the pattern
of  survivin  expression showed remarkable similarity to
that of flk1, a marker of vascular endothelium. We cannot
exclude a low level but diffuse expression of survivin in
adjacent tissues but this should not negate the specific role
of survivin during angiogenesis. First, we have confined
our examination to the SurUTR+ATG
MO embryos with char-
acteristic phenotypes and none of them showed overt tis-
sue necrosis at 48 hpf. The 20% embryos with severe
deformity have been excluded from analysis. Second, we
demonstrated that embryonic development is not overtly
delayed in the SurUTR+ATG
MO embryos as shown by the nor-
mal onset and pattern of pigmentation and heart beat
(data not shown). Finally, in the present study, survivin
expression appeared to be under VEGF regulation, provid-
ing a possible link between VEGF and embryonic angio-
genesis. Our findings were also consistent with those by
Pasquier et al. [20] in which over-expression of survivin in
Xenopus embryos induces endothelial cell proliferation
in-vivo.
Several observations in this study have remained unex-
plained. For instance, we did not observe a direct causal
link between increased apoptosis and the angiogenesis
defect in the SurUTR+ATG
MO embryos. Apoptosis was detect-
able not only in the axial vasculature, but also in the
developing brain and neural tube of the SurUTR+ATG
MO
embryos. Both in-vivo and in-vitro studies have demon-
strated that in addition to its anti-apoptotic function, sur-
vivin plays an important role in the regulation of cellular
proliferation and cytokinesis [1,2]. Recent study in Xeno-
pus embryos also showed that survivin expression induces
endothelial cell proliferation independent of apoptosis
[20]. Therefore, the relative modest TUNEL staining in the
axial vasculature did not preclude the role of survivin in
angiogenesis. It is also possible that survivin plays a non-
cell autonomous role in the angiogenesis process. Childs
et al. (2002) [21] demonstrated in zebrafish embryos the
migration of angioblasts from the aorta to the dorsal
aspect of the neural tube and to the inter-phase between
notochord and the somites, where they develop into
DLAV and ISV. Therefore, vascular patterning may depend
on signaling cues that direct the site of angiogenesis
sprouts. Whether the occurrence of apoptosis in the devel-
oping neural tube might have perturbed these signals
hence the formation of DLAV and ISV would have to be
carefully examined. The proposition may also explain the
lack of robust expression at the site of ISV and DLAV in
wild-type embryos. Furthermore, although survivin  is
expressed robustly in the axial vasculature, concomitant
expression was noted in the developing central nervous
system. The expression of survivin within these structures
needs to be defined in future study. Moreover, the devel-
oping eye and head structures in the survivin morphants
are generally smaller. Whether this reflected changes sec-
ondary to defective angiogenesis or alternative functions
of survivin during development have not been elucidated.
Finally, survivin gene in zebrafish has undergone duplica-
tion during evolution [22] and the function of the dupli-
cated gene would have to be further investigated.
Notwithstanding these limitations, our data still sup-
ported the proposition that survivin is involved in the reg-
ulation of angiogenesis during zebrafish development.
Regulation of survivin expression by vascular endothelial  growth factor (VEGF) at 96 hpf Figure 5
Regulation of survivin expression by vascular endothelial 
growth factor (VEGF) at 96 hpf. (a): Sub-intestinal vessels in 
uninjected Tg(fli1:EGFP)y1 embryos. (b): Injection of human 
VEGF (2 ng) gave rise to ectopic angiogenesis (arrows). 
There was no observable ectopic angiogenesis in the ISV (c): 
Axial and inter-segmental vessels in untreated Tg(fli1:EGFP)y1 
embryos. (d): Tg(fli1:EGFP)y1 embryos treated with VEGF 
tyrosine kinase receptor inhibitor (VEGFTKRI, 25 μmol/L) 
showing defective sprouting of inter-segmental vessels. (e): 
Injection of survivin mRNA did not reverse the defects seen 
in VEGFTKRI treated embryos. (f): Histogram showing the 
average survivin mRNA expression (expressed in fold-change) 
in untreated and VEGFTKRI treated embryos as well as in 
embryos injected with human VEGF. Results expressed in 
mean ± S.E.M. (n = 3 experiments using at least 20 embryos 
per experiments). When the three groups of data were com-
pared using Kruskal-Wallis Test, p-value = 0.016. When the 
data of uninjected vs VEGFTKRI treated embryos were com-
pared using Mann-Whitney U Test, p-value = 0.037.BMC Developmental Biology 2007, 7:50 http://www.biomedcentral.com/1471-213X/7/50
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Survivin  is strongly expressed in both solid organ and
hematological malignancies where it is associated with
treatment failure and a poor prognosis [2,3]. Loss of func-
tion studies have also demonstrated that survivin expres-
sion is linked to angiogenesis and tumorigenesis in gastric
and colonic cancers and has become a potential target for
anti-cancer therapy [23,24]. Our observation that survivin
regulates angiogenesis in zebrafish embryos highlights the
relevance of using zebrafish embryos in the screening for
survivin-based anti-cancer agents.
In summary, we demonstrate that survivin plays an
important role in angiogenesis during embryonic devel-
opment and may be one of the down-stream effectors of
VEGF signaling. Early hematopoiesis was not affected but
the role of survivin during late hematopoiesis remains to
be determined.
Methods
Zebrafish and morpholinos
Wild-type zebrafish (Danio rerio) were obtained from
local aquarium and were maintained and raised under
standard conditions at 28°C. Transgenic Tg(fli1:EGFP)y1
embryos were used to track endothelial cell populations.
Anti-sense morpholinos (MO) (Gene-Tools, OR, USA)
were designed to target the 5'untranslated region (UTR) or
sequences flanking and including the initiation codon
(ATG) of the zebrafish survivin gene. A splice-site (SS) MO
was designed to target the exon2-intron junction of the
survivin gene (SurSS-MO). A random sequence MO was
used as a control as described previously (Table 1). Proce-
dures for micro-injection, whole mount in-situ hybridiza-
tion, microangiography, TUNEL and caspase-3 activity
assays have been described previously [7,25,26].
Double in-situ hybridization
Wild-type (WT) embryos at 24 hpf were fixed with 4%
paraformaldehyde (PFA) and dehydrated. After stepwise
re-hydration, the embryos were incubated in pre-hybridi-
zation buffer (50% formamide, 5 × SSC, 50 μg/ml
heparin, 0.1% Tween20, 5 mg/ml rRNA in phosphate-
buffered saline, PBS) at 65°C followed by overnight incu-
bation with digoxigenin (DIG)- (either flk-1 or survivin-1)
and fluorescein-labeled riboprobe (α-embryonic globin)
at 65°C. The embryos were washed and incubated with
alkaline phosphatase (AP) conjugated anti-DIG antibody
(Roche Molecular Biochemicals, Mannheim, Germany)
for overnight at 4°C. Blue color was developed using
NBT/BCIP (Roche Molecular Biochemicals, Mannheim,
Germany) as substrate and the reaction was stopped with
0.5 mM EDTA in PBT. AP was destroyed by washing the
stained embryos with 0.1 M glycine-HCl, pH 2.2 in PBT
for 10 min twice. Background staining was removed by
washing the embryos in absolute ethanol with continuous
monitoring. After re-hydration to PBT, embryos were
incubated with AP conjugated anti-fluorescein antibody
Table 1: Sequences of oligos used.
Oligo Sequence
Morpholinos
SurATG TGC AAG ATC CAT TTT GTG GGA GGT T
SurUTR GTG GAA ATT AAA CAA AAG ACA ACC G
SurSS AGA CAC GGA CTC ACT CAG GGT CAT C
Random Sequence CCT CTT ACC TCA GTT ACA ATT TAT A
Primers for the cloning of survivin mRNA in riboprobe synthesis
ZF Surf CGG ATT TAT CTC GGT TGT CTT T
ZF Surr CAA CTT TCA CAA GTG ACA GAA CAC
Primers for the cloning of survivin UTR for 5'UTR survivin-GFP construct synthesis
ZF SurUTRf GCG GAT TTA TCT CGG TTG TCT
ZF SurUTRr CTT CCT CCC CCA TCG CAG TCT GG
Primers for RT-PCR for survivin mRNA in splice-site morpholino study
ZF Surf CAA CCT CCC ACA AAA TGG AT
ZF Surr GTC CAC AGT CTT CTT CAG CA
Primers for the cloning of survivin mRNA in rescue experiments
ZF Surf AAT CAA CAA GCA AGCGAG AC
ZF Surr CAA TTT ATT AAG CCC GAA TGC
Primers for real-time quantitative RT-PCR for survivin mRNA
ZF Surf CAC TCC AGA AAA CAT GGC TAA A
ZF Surr CCA TCC TTC CAG CTC TTT CABMC Developmental Biology 2007, 7:50 http://www.biomedcentral.com/1471-213X/7/50
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(Roche Molecular Biochemicals, Mannheim, Germany)
for overnight at 4°C and red color was developed using
INT/BCIP (Roche Molecular Biochemicals, Mannheim,
Germany) as substrate.
Synthesis of anti-sense mRNA riboprobe for survivin
The full length sequence of zebrafish survivin including
the 3' UTR was amplified by PCR (Table 1) from cDNA of
24 hpf embryos and subcloned into pGem-T vector
(pGEM-T Vector Systems, Promega, Madison, WI, USA). A
623 bp anti-sense survivin mRNA riboprobe was synthe-
sized from linearized vector containing the insert. A dig-
oxigenin labeled mRNA probe was synthesized by SP6
RNA polymerase according the manufacturer's protocols
(Roche Applied Science, Indianapolis, IN, USA). The size
and integrity of the synthesized riboprobe was confirmed
by RNA formaldehyde gel electrophoresis. Histological
assessment of stained embryos was performed on 5–7-μm
paraffin sections.
Construction of 5'UTR-survivin:GFP plasmids
The 5'UTR of survivin, including the target sequences of
SurUTR-MO and SurATG-MO, were amplified from 24 hpf
wild-type embryo cDNA (Table 1). PCR products were gel
purified and cloned in frame and immediately upstream
of the GFP coding sequence into vector pcDNA3.1/CT-
GFP-TOPO (Invitrogen, Carlsbad, CA, USA) and trans-
formed into chemically competent E. coli TOP10 (Invitro-
gen, Carlsbad, CA, USA). Plasmids containing the 5'UTR-
survivin:GFP fusion sequence were isolated and the
sequence of the DNA inserts verified using the GFP reverse
primer (5'-GGG TAA GCT TTC CGT ATG TAG C-3').
Preparation of survivin mRNA for rescue experiments
The complete coding sequence of survivin was TA-cloned
into pGEM-T vector (pGEM-T Vector Systems, Promega,
Madison, WI, USA) and the orientation of the insert con-
firmed by PCR (Table 1). mRNA transcripts were synthe-
sized from the T7 promoter of the Sal I digested pGEMT-
Sur sequence using the mMessage mMachine Kit
(Ambion, Austin, TX, USA).
Treatment of embryos with VEGF receptor tyrosine kinase 
inhibitors
Embryos were treated with an inhibitor of vascular
endothelial growth factor receptor tyrosine kinase (VEG-
FRTK inhibitors, Calbiochem, EMD Bioscience, CA, USA).
The embryos were incubated in inhibitor solution at 25
μmol/L (stock solution in DMSO at 10 mmol/L) from
one-cell stage onwards. They were dechorionated at 24
hpf with continuous exposure to inhibitors until 48 hpf.
Control experiments were set up from the same clutches
of embryos and were exposed to equal volume of DMSO
for comparison.
Vascular endothelial growth factor (VEGF) injection
Human VEGF protein (BD Bioscience, Bedford, MA, USA)
was prepared in 1 mg/mL in water. Embryos at 1–4 cell
stage were injected with VEGF (2 ng) into the yolk sac and
its effect on angiogenesis was examined at 96 hpf.
Real-time quantitative RT-PCR (Q-PCR)
cDNA from 48 and 96 hpf embryos were reverse tran-
scribed from RNA and Q-PCR for survivin was performed
using the SYBR green PCR master mix (Applied Biosys-
tems, Foster City, CA, USA). Expression level was pre-
sented as fold-change calculated using the comparative CT
method as described [27] with β-actin as the internal ref-
erence. Primer sequences for Q-PCR were shown in Table
1.
Statistical analysis
Results were expressed as mean ± SEM unless otherwise
stated. Comparisons between groups of data were evalu-
ated by Mann-Whitney U and Kruskal-Wallis Test where
appropriate. P-value of less than 0.05 was considered sta-
tistically significant.
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